Skip to main content

Accelr8 Pockets $200K After Licensing OptiChem Tech to NanoString, Nexterion

NEW YORK (GenomeWeb News) — Accelr8 Technology today said that NanoString Technologies has licensed its OptiChem coating technology to use on its soon-to-be-released nCounter molecular-identification platform.
Accelr8 also said that SCHOTT Nexterion has renewed its license to the OptiChem technology, which allows it to continue manufacturing and marketing its OptiChem-coated microarraying slides.
The company gets $200,000 in up-front license payments from the deals and is entitled to undisclosed "pre-paid minimum-guaranteed royalties."
Accelr8 said it will “now focus almost all of [its] resources” to develop its BACcel rapid bacterial-diagnostic system, which it also plans to out-license or leverage into “strategic partnerships."
The firm continues to “jointly publish scientific studies and support an exploratory research program” at the University of Groningen in The Netherlands for potential new OptiChem applications,” the company said in a statement.
"We are making rapid progress with the BACcel system and entering a new level of discussion with potential industry partners,” the company said.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.